ArticlePsoriasis (Auckland, N.Z.)2025

Effectiveness and Safety of Tildrakizumab in Elderly and Frail Elderly Psoriatic Patients Up to 2 years.

Luca Mastorino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.